A carregar...
Long-Term Successful Treatment of Indolent Systemic Mastocytosis With Omalizumab
This case study suggests that omalizumab may help prevent anaphylaxis and reduce disease burden associated with systemic mastocytosis, but further studies and formal clinical trials are needed to confirm these findings.
Na minha lista:
| Publicado no: | Fed Pract |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontline Medical Communications Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7870274/ https://ncbi.nlm.nih.gov/pubmed/33574649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12788/fp.0081 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|